JNJ DGAT2-A

Cat. No. M6850

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

JNJ DGAT2-A is a dGAT2 inhibitor (IC₅₀ = 140 nM). Exhibits >70-fold selectivity for DGAT2 over DGAT1 and MGAT2.

Molecular Weight	523.38
Formula	C24H16BrFN4O2S
CAS Number	1962931-71-0
Solubility (25°C)	DMSO 52.34 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related DGAT Products
PF-07202954 PF-07202954 is an orally active, weakly basic DGAT2 inhibitor with an IC50 of 10 nM for human DGAT2.PF-07202954 reduces hepatic triglycerides in an obese rat model.
ION224 ION224 is an antisense compound that targets DGAT-2 for studies related to non-alcoholic steatohepatitis (NASH).
PF-07055341 PF-07055341 is a DGAT1/2 inhibitor that can be used in studies related to non-alcoholic steatohepatitis (NASH).
Ervogastat Ervogastat is a DGAT2 inhibitor that can be used in studies related to non-alcoholic steatohepatitis (NASH).
Pradigastat Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects.

Catalog